The phrase "access development" is correct and usable in written English.
It can be used in contexts related to software, technology, or project management, referring to the process of gaining entry to or enhancing development resources or environments.
Example: "The team is focused on access development to ensure that all members can utilize the latest tools and technologies effectively."
Alternatives: "development access" or "access to development resources".
And the industry is complaining that it is almost impossible for a start up music company to access development money.
The new team will initially be focused on access development and is aimed at proving the utility of network analysis such that a push can be made for additional GCSB billets".
The document goes on to say that GCSB's "access development activities" will focus on the South Pacific "and entail closer partnering and engagement with DSD, NZSIS [New Zealand Security Intelligence Service] and Asis [Australian Secret Intelligence Service].
For the first time, individuals will be able to access a central data store using the world's top sources for development and aid data, through which they can access development statistics, and information.
The main proxy access development in 2017 related to proposals seeking to amend an existing proxy access bylaw to increase the number of shareholders permitted to constitute a nominating group.
Trump has not yet made any statements about the latest Dakota Access development—his transition team did not respond to my requests for comment but last week a spokesman indicated Trump's support for the original pipeline route, and specified that it "has nothing to do with his personal investments and everything to do with promoting policies that benefit all Americans".
It is based on the firm's alert, "Recent Proxy Access Developments," dated November 14, 2016, and available here.
myTomorrows is a Dutch startup that wants to disrupt the way patients with unmet medical needs access development-stage treatments — drugs that are still undergoing clinical trials and working there way through a lengthy regulatory approval process.
The Dutch startup wants to disrupt the way patients with unmet medical needs access development-stage treatments — drugs that are still undergoing clinical trials and working their way through a lengthy regulatory approval process, or are already approved in one country but not another.
myTomorrows, the Dutch startup that wants to disrupt the way patients with unmet medical needs access development-stage treatments — drugs that are still undergoing clinical trials and working their way through a lengthy regulatory approval process — has raised €4.5 million (~$6m) in new funding.
In the short term, it takes a commission from the biotech companies on its platform per patient who successfully accesses development-stage treatments, in recognition for the work myTomorrows carries out.
